Through its affiliation with the University Clinic of Giessen and Marburg GmbH, one of the largest university clinics in Germany, Philipps-Universität is part of a strongly research-oriented medical community whose members work together to cure diseases. In addition to the main research areas in the fields of tumorbiology and oncology, inflammation and immunity, infection biology and the study of anti-infective agents as well as "Neurosciences", fundamental areas in "Cell Biology" and "Gene Regulation". The research areas overlap and work closely with one another to examine causes and relationships in the development of tumor diseases. Basic research (Center for Tumor and Immune Biology [ZTI], Biomedical Research Center [BMFZ]) and point-of-care research (Carreras Leukemia Center, Anneliese Pohl Comprehensive Cancer Center Marburg) are located at Marburg. They share the common goal of improving therapeutic approaches. A strong complement is the Marburger Ionenstrahl-Therapiezentrum, which offers therapy options for tumors that are difficult or not yet treatable. Research into neurological and psychological disorders in a common context is also a major focus in medicine. Here, clinical neuroscientists work closely together with psychiatrists and psychologists. This is also made clear by the extensive network between the neurological institutions such as the Parkinson Network Allianz Marburg (PANAMA), the Stroke Network Marburg (MARS) and the Epilepsy Center Hessen (EZH). Research into anti-infective agents focuses on virology and vaccines, with the Marburg High-Security Virology Laboratory (BSL4) providing the necessary infrastructure. The university cooperates closely with Novartis Vaccines and Diagnostics GmbH, headquartered in Marburg, to develop flu vaccines.